Despite soaring global demand for healthcare, the challenge of profitably developing treatments has never been greater or more ethically complex. Can pharma giants strike the right balance?
Recent insights
4 febrero 2025
Navigating through to the end of legacy PFI
18 diciembre 2024
Australian Parliament passes Merger Reform Act
16 diciembre 2024
Australian Government responds to review of the Modern Slavery Act
29 noviembre 2024
Australian Privacy Reform Bill Tranche 1 passed Parliament: Key impacts for your business
23 octubre 2024
OAIC's New AI Guidance: Navigating the Privacy Landscape for Australian Businesses
17 septiembre 2024
Are you cyber ready? Australian businesses grapple with cyber resilience in 2024
17 septiembre 2024
Cyber risk escalates: Are Australian businesses keeping up?
17 septiembre 2024
On the minds of General Counsel
17 septiembre 2024
Keeping watch: An evolving set of risk and regulatory changes on the horizon
13 septiembre 2024
Australian Privacy Reform Bill Tranche 1: Key impacts for your business
12 septiembre 2024
AI governance: Practical tips for directors to take into their next board meeting
9 septiembre 2024
Australia releases new mandatory guardrails and voluntary standards on AI – what you need to know
Key contacts
Alan Montgomery
Partner, Head of Pharmaceuticals Sector, Chair of India Group, London
Chris Parker KC
Partner, Head of Pharmaceuticals Sector, London
Natalie Bryce
Partner, Brisbane